Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
When to choose an index fund depends on costs, diversification needs, and your time horizon; use these criteria to guide selection.
14,060 articlesVertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Two US-listed SUI ETFs debut with staking rewards, signaling a new era for crypto exposure in regulated markets. SUI ...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
MiMedx (MDXG) 2025 earnings scrutiny goes beyond one quarter. This guide breaks down what to watch in the Q4 call, ho...
Bubbles aren’t only about houses. A different kind of risk could be growing in the loan market, fueled by AI hype and...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
Influencer clashes over defamation put a spotlight on money, risk, and what you should scrutinize before backing ever...
Pershing Square seeks an NYSE debut for both its closed-end fund and parent, targeting a $5-$10 billion raise and a B...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
When a quarterly earnings call drops, investors seek signals that move prices. This practical guide uses the caap 202...